|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 2583978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12188562.8 |
| Date of filing the European patent application | 2008-02-22 | |
| (97) | Date of publication of the European application | 2013-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 710248 | 2007-02-23 | US | |
| 697646 | 2007-04-06 | US | |
| 984721 P | 2007-11-01 | US |
| (72) |
Schenk, Dale B., US
Masliah, Eliezer, US
Buttini, Manuel, J., US
Chilcote, Tamie, J., US
Rockenstein, Edward, US
Games, Kate, Dora, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
Prothena Biosciences Limited, Adelphi Plaza Upper George`s Street Dun Laoghaire, Co. Dublin, IE |
| (54) | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| Prevention and treatment of synucleinopathic and amyloidogenic disease |